Sleep trouble linked to heart risk in lung disease patients
NCT ID NCT07464184
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 60 adults with pulmonary hypertension (high blood pressure in the lungs) for 2 years. Researchers will measure breathing problems during sleep and heart rate changes to see how they relate to the disease. No new treatment is given; participants continue their usual care. The goal is to find better ways to predict and manage health risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTONOMIC NERVOUS SYSTEM DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chu Rouen
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill ease the strain of pulmonary arterial hypertension?
- Could a gut bacteria transplant ease a rare lung disease?
- AI eye scans could reveal hidden heart risk
- Can a diabetes drug help the heart burn fuel better in pulmonary hypertension?
- Stroke recovery: could a simple physical exam reveal hidden clues about energy and heart health?
- Could a simple mouth check reveal hidden heart risks?